|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
| Address1 | 1016 W Jackson Blvd |
Address2 | #1073 |
| City | Chicago |
State | IL |
Zip Code | 60607 |
Country | USA |
3. Principal place of business (if different than line 2)
| City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 400348610-12
|
||||||||
|
6. House ID# 403510000
|
||||||||
| TYPE OF REPORT | 8. Year | 2024 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
| 10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
| INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 12. Lobbying | 13. Organizations | ||||||||
| INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
| Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
|
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
|||||||||
| Signature | Digitally Signed By: Paul Melmeyer |
Date | 8/15/2024 1:38:35 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
Joined coalition letter supporting appropriations for newborn screening
Testified in front of the ACHDNC on newborn screening
Prepared efforts for reauthorization of the Newborn Screening Saves Lives Reauthorization Act
Encouraged action on telehealth legislation to the Energy and Commerce Committee
Supported H.R. 7623, the Telehealth Modernization Act of 2024
Supported H.R. 7858, Telehealth Enhancement for Mental Health Act and the Telehealth Modernization Act:
Supported HHSs final rule on section 1557 of the ACA
Joined Coalition Comments on 2026 Notice of Benefit and Payment Parameters (6.7.24)
Joined coalition comments on Medicare Payment Plans
Supported the ALS Better Care Act
Joined Coalition Comments to CMS in Response to RFI on Medicare Advantage Data
Joined Coalition Comments on Pending National Coverage Analysis for Standing Systems in Power Wheelchairs
Provided comments to Energy and Commerce Committee on Medicaid access
Advocated for the protection of the Medicaid program to the White House and Congress
Supported H.R. 7383, Retaining Access and Restoring Exclusivity (RARE) Act
Supported H.R. 7384, Creating Hope Reauthorization Act of 2024
Supported the amended Give Kids a Chance Act
Supported the Benefit Act
Supported the MINI Act
Supported the NIH Clinical Trial Diversity Act
Supported H.R. 4758, Accelerating Kids Access to Care Act
Supported the introduction of legislation that increases access to genetic testing and genetic counselors
Supported the Access to Genetic Counseling Services Act
Advocated for provisions addressing problems within the pharmacy benefit manager industry
Supported the introduction of legislation that amends the anti-kickback statute to allow companies to cover the costs of traveling to obtain therapies
Supported robust funding for NCATS
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Centers For Disease Control & Prevention (CDC), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Health Resources & Services Administration (HRSA), Justice - Dept of (DOJ)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Melmeyer |
|
|
|
Joel |
Cartner |
|
|
|
Shannon |
Wood |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code AVI
16. Specific lobbying issues
Advocated for stronger protections of individuals with disabilities when engaging with TSA
Submitted coalition comments to DOT on the comment deadline extension on their proposed wheelchair users accessible air travel rule
Advocated for the final passage of the FAA reauthorization
Filed joint and individual comments on DOTs proposed rule on air travel accessibility
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Federal Aviation Administration (FAA), Transportation - Dept of (DOT), Transportation Security Administration (TSA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Melmeyer |
|
|
|
Joel |
Cartner |
|
|
|
Shannon |
Wood |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
Supported enhanced funding for NCATS, NIAMS, and the entire NIH
Supported robust appropriations for the newborn screening program.
Supported funding of ALS research, expanded access, and more
Joined comments on education appropriations for those with disabilities
Joined Coalition Comments on Supporting Non-Defense Discretionary Federal Funding in FY25
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Food & Drug Administration (FDA), Centers For Disease Control & Prevention (CDC), Health & Human Services - Dept of (HHS), Health Resources & Services Administration (HRSA), Defense - Dept of (DOD), Education - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Melmeyer |
|
|
|
Joel |
Cartner |
|
|
|
Shannon |
Wood |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MED
16. Specific lobbying issues
Joined coalition letter supporting appropriations for newborn screening
Testified in front of the ACHDNC on newborn screening
Prepared efforts for reauthorization of the Newborn Screening Saves Lives Reauthorization Act
Supported H.R. 7383, Retaining Access and Restoring Exclusivity (RARE) Act
Supported H.R. 7384, Creating Hope Reauthorization Act of 2024
Supported the amended Give Kids a Chance Act
Supported the Benefit Act
Supported the NIH Clinical Trial Diversity Act
Supported robust funding for NCATS
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS), Natl Institutes of Health (NIH), Health Resources & Services Administration (HRSA), Centers For Medicare and Medicaid Services (CMS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Melmeyer |
|
|
|
Joel |
Cartner |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
Joined coalition comments on Medicare Payment Plans
Supported the ALS Better Care Act
Joined Coalition Comments to CMS in Response to RFI on Medicare Advantage Data
Joined Coalition Comments on Pending National Coverage Analysis for Standing Systems in Power Wheelchairs
Provided comments to Energy and Commerce Committee on Medicaid access
Advocated for the protection of the Medicaid program to the White House and Congress
Supported the MINI Act
Supported H.R. 4758, Accelerating Kids Access to Care Act
Supported the introduction of legislation that increases access to genetic testing and genetic counselors
Encouraged action on telehealth legislation to the Energy and Commerce Committee
Supported H.R. 7623, the Telehealth Modernization Act of 2024
Supported H.R. 7858, Telehealth Enhancement for Mental Health Act and the Telehealth Modernization Act:
Supported the Access to Genetic Counseling Services Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Melmeyer |
|
|
|
Joel |
Cartner |
|
|
|
Shannon |
Wood |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code INS
16. Specific lobbying issues
Encouraged action on telehealth legislation to the Energy and Commerce Committee
Supported H.R. 7623, the Telehealth Modernization Act of 2024
Supported H.R. 7858, Telehealth Enhancement for Mental Health Act and the Telehealth Modernization Act:
Supported HHSs final rule on section 1557 of the ACA
Joined Coalition Comments on 2026 Notice of Benefit and Payment Parameters (6.7.24)
Joined coalition comments on Medicare Payment Plans
Supported the ALS Better Care Act
Joined Coalition Comments to CMS in Response to RFI on Medicare Advantage Data
Joined Coalition Comments on Pending National Coverage Analysis for Standing Systems in Power Wheelchairs
Provided comments to Energy and Commerce Committee on Medicaid access
Advocated for the protection of the Medicaid program to the White House and Congress
Supported H.R. 4758, Accelerating Kids Access to Care Act
Supported the introduction of legislation that increases access to genetic testing and genetic counselors
Supported the Access to Genetic Counseling Services Act
Advocated for provisions addressing problems within the pharmacy benefit manager industry
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Melmeyer |
|
|
|
Joel |
Cartner |
|
|
|
Shannon |
Wood |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code PHA
16. Specific lobbying issues
Encouraged action on telehealth legislation to the Energy and Commerce Committee
Supported H.R. 7623, the Telehealth Modernization Act of 2024
Supported H.R. 7858, Telehealth Enhancement for Mental Health Act and the Telehealth Modernization Act:
Supported HHSs final rule on section 1557 of the ACA
Joined Coalition Comments on 2026 Notice of Benefit and Payment Parameters (6.7.24)
Joined coalition comments on Medicare Payment Plans
Joined Coalition Comments to CMS in Response to RFI on Medicare Advantage Data
Supported H.R. 7383, Retaining Access and Restoring Exclusivity (RARE) Act
Supported H.R. 7384, Creating Hope Reauthorization Act of 2024
Supported the amended Give Kids a Chance Act
Supported the introduction of legislation that increases access to genetic testing and genetic counselors
Advocated for provisions addressing problems within the pharmacy benefit manager industry
Supported the introduction of legislation that amends the anti-kickback statute to allow companies to cover the costs of traveling to obtain therapies
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Food & Drug Administration (FDA), Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Natl Institutes of Health (NIH), Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Melmeyer |
|
|
|
Joel |
Cartner |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TRA
16. Specific lobbying issues
Submitted coalition comments to DOT on the comment deadline extension on their proposed wheelchair
users accessible air travel rule
Advocated for the final passage of the FAA reauthorization
Filed joint and individual comments on DOTs proposed rule on air travel accessibility
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, Federal Aviation Administration (FAA), U.S. HOUSE OF REPRESENTATIVES, Transportation - Dept of (DOT)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Melmeyer |
|
|
|
Joel |
Cartner |
|
|
|
Shannon |
Wood |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
Supported the RISE Act
Supported the Full Funding is the Right IDEA Act
Joined comments on education appropriations for those with disabilities
17. House(s) of Congress and Federal agencies Check if None
Education - Dept of, U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Melmeyer |
|
|
|
Shannon |
Wood |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LAW
16. Specific lobbying issues
Joined Coalition Comments to DOJ on Accessible Voting (5.30.24)
17. House(s) of Congress and Federal agencies Check if None
Justice - Dept of (DOJ)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Paul |
Melmeyer |
|
|
|
Joel |
Cartner |
|
|
|
Shannon |
Wood |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code WEL
16. Specific lobbying issues
Joined Coalition Comments on SNAP in House Farm Bill Reauthorization
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Agriculture - Dept of (USDA)
18. Name of each individual who acted as a lobbyist in this issue area
| First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Shannon |
Wood |
|
|
|
Paul |
Melmeyer |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
| Address |
|
||||||
| City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
| City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
| 1 |
|
3 |
|
||||||
| 2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
| Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
||||||||||||||
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
| 1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% | |||||||||||||
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
| 1 | 3 | 5 |
| 2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Lobbyist Name | Description of Offense(s) |